Literature DB >> 14499311

Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.

Koichi Ohara1, Shigeru Tanabu, Kimiko Yoshida, Kazuhisa Ishibashi, Keiko Ikemoto, Haruo Shibuya.   

Abstract

OBJECTIVE: This study was carried out to evaluate the influence of CYP2D6 polymorphism and smoking on the plasma clearance of haloperidol (HAL) levels, accounting for the antipsychotic dose, body weight, and coadministration of other drugs.
METHODS: Subjects were 110 Japanese patients (66 male, 44 female) diagnosed with schizophrenia, dementia, or mood disorder and treated orally with HAL. Venous blood was obtained from each patient to determine the HAL concentration/dose (C/D) ratio (plasma concentration of HAL divided by the daily dose of HAL per body weight) and for CYP2D6 genotyping.
RESULTS: There was no significant difference in the HAL C/D ratio between nonsmokers and smokers. In patients with a non-2D6*10 homozygous genotype, smokers had a significantly lower HAL C/D ratio than nonsmokers, whereas smokers with a 2D6*10 homozygous genotype had a significantly higher HAL C/D ratio than those with a non-2D6*10 homozygous genotype.
CONCLUSION: Our results suggest that the effect of smoking on the HAL C/D ratio depends on the CYP2D6*10 genotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499311     DOI: 10.1016/S0278-5846(03)00154-4

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Effect of gender and age on the pharmacokinetics of repinotan.

Authors:  Roland Heinig; Pavur Sundaresan; Anita Shah; Michael Boettcher
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.

Authors:  Lin Jiang; Peter Saetre; Elena Jazin; Eva Lindholm Carlström
Journal:  BMC Pharmacol       Date:  2009-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.